Filter by: Subject

Filter by: Subject

Results Per Page:

Human immunodeficiency virus (HIV) (22)
Sexually transmitted infection (STI) (17)
South Africa (SA) (14)
SDG-03: Good health and well-being (7)
Chlamydia trachomatis (6)
Mycobacterium tuberculosis (MTB) (6)
Pregnancy (6)
Bedaquiline (5)
Men who have sex with men (MSM) (5)
Neisseria gonorrhoeae (5)
Sub-Saharan Africa (SSA) (5)
Women (5)
Antiretroviral therapy (ART) (4)
Infection (4)
Pregnant women (4)
Rural South Africa (4)
Tuberculosis (TB) (4)
Africa (3)
Clofazimine (3)
Molecular detection (3)
Preterm birth (3)
Trichomonas vaginalis (3)
Vaginal discharge syndrome (VDS) (3)
Antenatal care (ANC) (2)
Antimicrobial resistance (AMR) (2)
Bacterial vaginosis (BV) (2)
Chlamydia trachomatis (CT) (2)
Community health worker (CHW) (2)
Correspondence (2)
Linezolid (2)
Low-resource setting (2)
Lymphogranuloma venereum (LGV) (2)
Management (2)
Microbiome (2)
Multi-drug resistant tuberculosis (MDR-TB) (2)
Mutation (2)
Mycobacterium tuberculosis (2)
Mycoplasma genitalium (2)
Mycoplasma genitalium infection (2)
Neisseria gonorrhoeae infection (2)
Polymerase chain reaction (PCR) (2)
Pyrazinamide resistance (2)
Real-time PCR (2)
Risk factors (2)
Screening (2)
Sexually transmitted disease (STD) (2)
Syndromic management (2)
Syphilis (2)
Systematic review (2)
Treatment (2)
Vaginal dysbiosis (2)
Vaginal microbiota (VMB) (2)
Whole-genome sequencing (WGS) (2)
Acquired immune deficiency syndrome (AIDS) (1)
Adolescent girls and young women (AGYW) (1)
Adult gonorrhea (1)
Adverse birth outcomes (1)
Adverse perinatal outcomes (1)
Age (1)
Anaerobic vaginitis (AV) (1)
Analysis of data (1)
Antifungal susceptibility testing (1)
Antimicrobial drug resistance (1)
AtpE mutations (1)
Azithromycin (1)
Azithromycin (AZM) (1)
Bacteremia (1)
Bacterial disease (1)
Bacterial DNA load (BDL) (1)
Bacterial vaginosis (1)
Biofilm (1)
Birth outcomes (1)
Birth weight (1)
Blindness (1)
Candida albicans (1)
Canonical variant (1)
Capreomycin (1)
Ceftriaxone (1)
Challenges (1)
Children (1)
China (1)
Chronic obstructive pulmonary disease (COPD) (1)
Ciprofloxacin (1)
Clofazimine (CFZ) (1)
Community-based strategies (1)
Complex (1)
Complications (1)
Condom use (1)
Core transmission groups (1)
Cost-effectiveness (1)
Cross-resistance (1)
Culture (1)
Cutaneous disease (1)
Cutaneous tuberculosis (1)
Data audits (1)
Data quality (1)
Data use practices (1)
Death (1)
Diagnosis (1)
DNA stability (1)